<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92538">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02074254</url>
  </required_header>
  <id_info>
    <org_study_id>2012E0196</org_study_id>
    <nct_id>NCT02074254</nct_id>
  </id_info>
  <brief_title>Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors</brief_title>
  <official_title>Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaheen Islam</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake
      Inhibitors
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a retrospective review of our experience with bleeding complication in the
      presence of antiplatelet and SSRI therapy and compare the complications with those who were
      not on antiplatelet agents or SSRI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>a retrospective review of our experience with bleeding complication in the presence of antiplatelet and SSRI therapy and compare the complications with those who were not on antiplatelet agents or SSRI</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Tracheostomy Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study is being done to evaluate the safety of percutaneous tracheostomy in patients
        taking antiplatelet agents such as aspirin and/ or clopidogrel or selective serotonin
        reuptake inhibitors. We will identify all patients age 18 or older who have undergone
        percutaneous tracheostomy by interventional pulmonology at OSUMC and access their PHI to
        record variables (see data collection form).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  on antiplatelet therapy or selective serotonin reuptake inhibitors(SSRI)

        Exclusion Criteria:

          -  N/A
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaheen Islam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OSUMC</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaheen Islam, MD</last_name>
      <phone>614-293-4925</phone>
      <email>melissa.michetti@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Janice Drake, CRT</last_name>
      <phone>614-366-2287</phone>
      <email>janice.drake@osumc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital, OSUMC 473 W 12th Ave</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaheen Islam, MD</last_name>
      <phone>614-293-4925</phone>
      <email>shaheen.islam@osumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Ohio State University</investigator_affiliation>
    <investigator_full_name>Shaheen Islam</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Serotonin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Serotonin Uptake Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
